News Story #19395
A Look at the Theoretical and Practical Advantages of Serum Free Light Chain Immunoassays
Read MorePosted by Clinical Lab Products | Apr 3, 2004 | Miscellaneous |
A Look at the Theoretical and Practical Advantages of Serum Free Light Chain Immunoassays
Read MorePosted by Clinical Lab Products | Apr 2, 2004 | Cancer, Cerebrovascular, Miscellaneous, Stroke |
By Renee DiIulio Proteomics will soon enable speedy, sensitive, specific diagnosis of ischemic stroke. This will result in rapid treatment and improved outcomes for patients. “The future, for the general physician, lies in genomics, or anal
Read MorePosted by Clinical Lab Products | Apr 1, 2004 | Cancer, Miscellaneous |
New Products and Aggressive Initiatives Help Reference and Specialty Labs Boost Revenues
Read MorePosted by Clinical Lab Products | Mar 10, 2004 | Miscellaneous |
Dade Behring Signs Manufacturing Licensing Agreement for FSAP Dade Behring and Aventis Behring LLC have signed a license agreement that provides Dade Behring with worldwide in vitro diagnostic rights to any Aventis Behring inventions that relate t
Read MorePosted by Clinical Lab Products | Mar 4, 2004 | Cerebrovascular, Miscellaneous |
Biomarkers at Bedside: i-STAT’s Point-of-Care Test Produces Cardiac Biomarker Troponin Results Withs
Read More